1
|
Hasvold LA, Sheppard GS, Wang L, Fidanze SD, Liu D, Pratt JK, Mantei RA, Wada CK, Hubbard R, Shen Y, Lin X, Huang X, Warder SE, Wilcox D, Li L, Buchanan FG, Smithee L, Albert DH, Magoc TJ, Park CH, Petros AM, Panchal SC, Sun C, Kovar P, Soni NB, Elmore SW, Kati WM, McDaniel KF. Methylpyrrole inhibitors of BET bromodomains. Bioorg Med Chem Lett 2017; 27:2225-2233. [DOI: 10.1016/j.bmcl.2017.02.057] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2017] [Revised: 02/17/2017] [Accepted: 02/23/2017] [Indexed: 11/30/2022]
|
2
|
Sweis RF, Wang Z, Algire M, Arrowsmith CH, Brown PJ, Chiang GG, Guo J, Jakob CG, Kennedy S, Li F, Maag D, Shaw B, Soni NB, Vedadi M, Pappano WN. Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2. ACS Med Chem Lett 2015; 6:695-700. [PMID: 26101576 DOI: 10.1021/acsmedchemlett.5b00124] [Citation(s) in RCA: 49] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2015] [Accepted: 04/29/2015] [Indexed: 12/13/2022] Open
Abstract
A lack of useful small molecule tools has precluded thorough interrogation of the biological function of SMYD2, a lysine methyltransferase with known tumor-suppressor substrates. Systematic exploration of the structure-activity relationships of a previously known benzoxazinone compound led to the synthesis of A-893, a potent and selective SMYD2 inhibitor (IC50: 2.8 nM). A cocrystal structure reveals the origin of enhanced potency, and effective suppression of p53K370 methylation is observed in a lung carcinoma (A549) cell line.
Collapse
Affiliation(s)
- Ramzi F. Sweis
- Discovery
Research, AbbVie, Inc., 1 North Waukegan Road, North
Chicago, Illinois 60064, United States
| | - Zhi Wang
- Discovery
Research, AbbVie, Inc., 1 North Waukegan Road, North
Chicago, Illinois 60064, United States
| | - Mikkel Algire
- Discovery
Research, AbbVie, Inc., 1 North Waukegan Road, North
Chicago, Illinois 60064, United States
| | - Cheryl H. Arrowsmith
- Structural
Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada
- Ontario
Cancer Institute and Department of Medical Biophysics, University of Toronto, Toronto, ON M5G
2M9, Canada
| | - Peter J. Brown
- Structural
Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada
| | - Gary G. Chiang
- Discovery
Research, AbbVie, Inc., 1 North Waukegan Road, North
Chicago, Illinois 60064, United States
| | - Jun Guo
- Discovery
Research, AbbVie, Inc., 1 North Waukegan Road, North
Chicago, Illinois 60064, United States
| | - Clarissa G. Jakob
- Discovery
Research, AbbVie, Inc., 1 North Waukegan Road, North
Chicago, Illinois 60064, United States
| | - Steven Kennedy
- Structural
Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada
| | - Fengling Li
- Structural
Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada
| | - David Maag
- Discovery
Research, AbbVie, Inc., 1 North Waukegan Road, North
Chicago, Illinois 60064, United States
| | - Bailin Shaw
- Discovery
Research, AbbVie, Inc., 1 North Waukegan Road, North
Chicago, Illinois 60064, United States
| | - Nirupama B. Soni
- Discovery
Research, AbbVie, Inc., 1 North Waukegan Road, North
Chicago, Illinois 60064, United States
| | - Masoud Vedadi
- Structural
Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada
- Department
of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8, Canada
| | - William N. Pappano
- Discovery
Research, AbbVie, Inc., 1 North Waukegan Road, North
Chicago, Illinois 60064, United States
| |
Collapse
|
3
|
Sweis RF, Pliushchev M, Brown PJ, Guo J, Li F, Maag D, Petros AM, Soni NB, Tse C, Vedadi M, Michaelides MR, Chiang GG, Pappano WN. Discovery and development of potent and selective inhibitors of histone methyltransferase g9a. ACS Med Chem Lett 2014; 5:205-9. [PMID: 24900801 DOI: 10.1021/ml400496h] [Citation(s) in RCA: 126] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2013] [Accepted: 01/02/2014] [Indexed: 12/12/2022] Open
Abstract
G9a is a histone lysine methyltransferase responsible for the methylation of histone H3 lysine 9. The discovery of A-366 arose from a unique diversity screening hit, which was optimized by incorporation of a propyl-pyrrolidine subunit to occupy the enzyme lysine channel. A-366 is a potent inhibitor of G9a (IC50: 3.3 nM) with greater than 1000-fold selectivity over 21 other methyltransferases.
Collapse
Affiliation(s)
- Ramzi F. Sweis
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - Marina Pliushchev
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - Peter J. Brown
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - Jun Guo
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - Fengling Li
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - David Maag
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - Andrew M. Petros
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - Nirupama B. Soni
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - Chris Tse
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - Masoud Vedadi
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - Michael R. Michaelides
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - Gary G. Chiang
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| | - William N. Pappano
- Discovery Research, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
| |
Collapse
|
4
|
Gracias V, Ji Z, Akritopoulou-Zanze I, Abad-Zapatero C, Huth JR, Song D, Hajduk PJ, Johnson EF, Glaser KB, Marcotte PA, Pease L, Soni NB, Stewart KD, Davidsen SK, Michaelides MR, Djuric SW. Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett 2008; 18:2691-5. [PMID: 18362070 DOI: 10.1016/j.bmcl.2008.03.021] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2008] [Revised: 03/05/2008] [Accepted: 03/06/2008] [Indexed: 11/18/2022]
Abstract
We report the discovery of the pyrimido-diazepine scaffolds as novel adenine mimics. Structure-based design led to the discovery of analogs with potent inhibitory activity against receptor tyrosine kinases, such as KDR, Flt3 and c-Kit. Compound 14 exhibited low nanomolar KDR enzymatic and cellular potencies (IC(50)=9 and 52 nM, respectively).
Collapse
Affiliation(s)
- Vijaya Gracias
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60044, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Ji Z, Ahmed AA, Albert DH, Bouska JJ, Bousquet PF, Cunha GA, Diaz G, Glaser KB, Guo J, Harris CM, Li J, Marcotte PA, Moskey MD, Oie T, Pease L, Soni NB, Stewart KD, Davidsen SK, Michaelides MR. 3-Amino-benzo[d]isoxazoles as Novel Multitargeted Inhibitors of Receptor Tyrosine Kinases. J Med Chem 2008; 51:1231-41. [DOI: 10.1021/jm701096v] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Zhiqin Ji
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Asma A. Ahmed
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Daniel H. Albert
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Jennifer J. Bouska
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Peter F. Bousquet
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - George, A. Cunha
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Gilbert Diaz
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Keith B. Glaser
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Jun Guo
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Christopher M. Harris
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Junling Li
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Patrick A. Marcotte
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Maria D. Moskey
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Tetsuro Oie
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Lori Pease
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Nirupama B. Soni
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Kent D. Stewart
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Steven K. Davidsen
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| | - Michael R. Michaelides
- Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100, and Abbott Bioresearch Center, 100 Research Drive, Worcester, Massachusetts 01605-5314
| |
Collapse
|
6
|
Affiliation(s)
- N B Soni
- SpR Paediatrics, Glan Clwyd Hospital, Rhyl, Wales, UK.
| | | | | |
Collapse
|